ArticleFrontiers in immunology2022

Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B:9-23 in autoimmune diabetes.

Janet M Wenzlau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.